Purchases and Sales Made in Q4 2024 in Kal Vista Pharmaceuticals, Inc. (KALV)
This table provides information about the institutional ownership of Kal Vista Pharmaceuticals, Inc. (KALV) during Q4 2024. The information is specifically focused on institutions that hold shares of KalVista Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 14, 2025
Q4 2024
|
Hennion & Walsh Asset Management, Inc.
|
BUY
|
- |
74.8KNew |
$605K - $935K
|
74.8K
$661K
|
|
|
Jan 23, 2025
Q4 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
2.04K+ 24.66% |
$16.5K - $25.5K
|
10.3K
$91.3K
|
|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
BUY
|
- |
1.32K+ 10.0% |
$10.7K - $16.5K
|
14.5K
$128K
|
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
877+ 1.74% |
$7.09K - $11K
|
51.2K
$452K
|
|
|
Jan 02, 2025
Q4 2024
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
605+ 1025.42% |
$4.89K - $7.56K
|
664
$5.87K
|
|
|
Jan 28, 2025
Q4 2024
|
Bryn Mawr Trust CO
Bryn Mawr, PA |
BUY
|
- |
415New |
$3.36K - $5.19K
|
415
$3.67K
|
|
|
Jan 02, 2025
Q4 2024
|
Versant Capital Management, Inc
|
BUY
|
- |
166New |
$1.34K - $2.08K
|
166
$1.47K
|
|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
110New |
$890 - $1.38K
|
110
$972
|
|
|
Jan 27, 2025
Q4 2024
|
Mirae Asset Global Investments Co., Ltd.
|
BUY
|
- |
65+ 4.17% |
$526 - $813
|
1.62K
$14.3K
|
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-26- 0.6% |
$210 - $325
|
4.34K
$38.4K
|